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doi:10.1016/j.ejvs.2009.05.002Abstract Background: Recent developments with fenestrated and branched stent grafts have
opened the way to treat complex aortic aneurysms involving the visceral arteries. Early reports
on endovascular treatment of thoraco-abdominal aneurysms have demonstrated the feasibility
of the technique. Given the sparse literature, its safety has not been established yet.
Methods: A literature review was conducted, and the results of our own series of 30 patients
treated with a custom-made Zenith device with fixed branches are presented. Most of the
patients were refused open surgery mainly for the extent of the disease combined with co-
morbidity, which included inmost patients a combination of several risk factors. Themean aneu-
rysm size was 70 mmand the extent of the aneurysmwas type I in eight cases, type II in five, type
III in 12 and type IV in five patients.
Results: Technical success in our series was achieved in 93% (28/30). Two out of 97 (2%) targeted
vessels were lost. In one patient, a renal artery ruptured during insertion of the bridging stent
graft. In a second patient, a coeliac artery could not be catheterised and was lost. The 30-day
mortality was 6.7% and corroborated with 5.5% in the largest series reported so far. The 6months
and 1-year survival were 89.3% and 76.0%, respectively.
Conclusion: The results of fully endovascular repair of selected thoraco-abdominal aneurysms
are promising. A learning curve should be expected. Anatomical limitations such as extremely
tortuous vessels and access problems should be taken into account, as well as the quality of
the targeted side branches. Although longer-term results need to be awaited, it is likely that
endovascular repair of thoraco-abdominal aneurysms will become a preferential treatment
option for many patients in the future.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.)50 3613382; fax: þ31 (0)50 3611745.
hir.umcg.nl (E.L. Verhoeven).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
156 E.L. Verhoeven et al.Thoraco-abdominal aortic aneurysms (TAAAs) involve both experienced endovascular centres throughout the world isthe thoracic and abdominal aorta and are relatively
uncommon. If left untreated, these patients are at risk of
aneurysm rupture and death.1 Conventional open treat-
ment, however, is still associated with high mortality and
morbidity rates. This remains true despite advancements in
perioperative management, such as application of intra-
operative adjuncts, and improved postoperative care.2
These complex aneurysms still represent a real challenge to
the surgeon. In 2003, Cowan Jr. et al. reported the results
from a nationwide discharge database representing 20% of
the US hospitals and including 1542 patients with TAAA.3 The
in-hospital postoperative mortality rate after elective repair
was 22.3%, with higher rates in surgeons and hospitals with
lower volumes. Postoperative complications are often
severe and include myocardial infarction and ischaemia,
respiratory insufficiency with prolonged ventilation and
acute renal failure. One-year survival was reported to be as
low as 69% in a population-based study.4 In addition, there is
an inherent risk for paraplegia depending on the extent of
the aneurysm and its repair. All these factors, and para-
plegia as a separate factor, have been identified as predic-
tors for mortality, also at the longer term.5 In recent years,
a few specialised high-volume centres have achieved oper-
ative mortality rates with open repair as low as 5e12%, with
good performance scores as well.6,7 Nevertheless, due to the
major impact on the patient, open surgery is only justified in
those patients who are in reasonably healthy condition and
present with larger aneurysms. Therefore, there is an
obvious need for improvement, and alternative treatment
options have been explored.
After its first introduction in 1991, endovascular repair
(EVAR) of aortic abdominal aneurysm (AAA) has become
standard medical care in many centres. Still, a major
limitation of EVAR was the necessity of a suitable proximal
portion of normal aorta (i.e., proximal neck) to serve as
a sealing zone for the stent graft. The solution to this
problem was the introduction of customised stent grafts
with fenestrations and branches to incorporate the vital
side branches of the aorta. Advances in fenestrated endo-
vascular repair techniques (F-EVAR) over the past 10 years
opened the way to treat short-necked and juxtarenal
aneurysms. The F-EVAR technique has reached maturity
with over 2000 cases having been performed worldwide.
Published results, albeit from selected centres, are excel-
lent, and durability of the technique equally seems good.8e15
The development of branched grafts (i.e., grafts with
directional side branches) resulted in the first attempts to
treat TAAA.16 The specific advantages, disadvantages and
features of the fenestrated versus branched grafts have
been elaborated before.17
In this article, we review the current literature on
fenestrated and branched stent grafts for endovascular TAAA
repair, present the results of the first 30 cases performed and
discuss shifts in paradigms for future treatment of TAAA.
Current Literature on Fenestrated and
Branched Endovascular TAAA Repair
Up to now, EVAR of TAAA has primarily been reserved to
a few pioneering centres, but widespread in larger andongoing. Chuter et al. were the first to treat a TAAA with
a multi-branched stent graft.16,18 In 2001, they published
the case of a 76-year-old man with a type III TAAA and
a contained rupture of a supracoeliac ulcer treated using
this novel approach. The aneurysm was treated with
a custom-made device with two 25-mm downward branches
for the coeliac trunk and the superior mesenteric artery, as
well as two 5-mm stumps for the renal arteries. On the first
postoperative day, two additional stents were placed to
prevent kinking. Despite technical success, the patient
developed paraplegia on the second postoperative day. The
repair covered the entire abdominal and half of the
descending thoracic aorta, which was ulcerated and
ruptured, and the rupture was believed to have contributed
to the development of paraplegia.
The largest series reported so far includes a cohort of 73
patients, as published in 2007 and operated on in The
Cleveland Clinic Foundation, Cleveland, Ohio, USA.19 In
that series, there were 28 types I, II or III and 45 type IV
TAAAs. The mean aneurysm size was 7.1 cm (range: 4.5e
11.3 cm). General anaesthesia was used in 47% of the
patients and regional anaesthesia in 53%. The devices used
were all variants of the Zenith device (Cook Medical Inc.,
Bloomington, IN, USA). There were no conversions to open
surgery nor ruptures post-treatment. Technical success was
achieved in 93% of patients (68 out of 73). The 30-day
mortality rate was 5.5% (four out of 73). Of the total of 73
patients, major perioperative complications occurred in 11
(14%) patients and included paraplegia in two (2.7%), new
onset of dialysis in one (1.4%), prolonged ventilator support
in five (6.8%), myocardial infarction in four (5.5%) and
minor haemorrhagic stroke in another (1.4%). A majority of
patients had no complications. The mean length of stay was
8.6 days. At follow-up, six deaths had occurred. There were
no instances of stent migration nor aneurysmal growth.
These 73 patients were also included in a larger series of
patients also comprising repair of descending thoracic
aneurysms.20 In a direct comparison with open repair, no
significant difference in the incidence of mortality or spinal
cord ischaemia was found between EVAR and open repair.
Multivariate analysis showed that the extent of the disease
(types IeIV) was the primary factor in the development of
spinal cord ischaemia in both the treatment modalities.
The results of other published cases/series with endo-
vascular TAAA repair are summarised in Table 1.21e27
Groningen Series
Patient characteristics and technical details
Up to April 2009, experience included a total of 245
fenestrated and branched stent grafts for aneurysmal
disease. The indications for treatment were short-necked
AAA (nZ 86), juxtarenal AAA (nZ 74), suprarenal AAA
(nZ 11), TAAA (nZ 34), arch aneurysm (nZ 7) and iliac
aneurysm (nZ 33).
Experience with regards to endovascular repair of TAAA
is limited to 34 patients, of which four patients were
treated in another hospital under supervision, and follow-
up not complete. From the remaining 30 patients, complete
Table 1 Results with branched and fenestrated endovascular repair for TAAA in the literature.
Authors Year No Extent of disease Technical success 30-day mortality 1-Year survival
Chuter16,18(a) 2001 1 TAAA III 100% e e
Bleyn21 2002 1 TAAA IV 100% 0% e
Anderson22 2005 4 TAAA II (nZ 2), IV (nZ 2) 75% 25% 75%
Greenberg23(b) 2006 9 e 89% 0% 78%
Simi24 2007 1 TAAA III 100% e e
Roselli19(b) 2007 73 TAAA I, II, III (nZ 28), IV (nZ 45) 93% 5.5% 81%
Chuter25 2008 22 e 100% 9.1% 77%
Gillling-Smith26 2008 6 TAAA II (nZ 2), TAAA III (nZ 2) 100% 0% 100%
TAAA IV (nZ 2)
Bicknell27 2009 8 TAAA I (nZ 2), TAAA III (nZ 2) 100% 0% e
TAAA IV (nZ 4)
a Same case.
b same series.
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and seven women with a mean age of 71.5 years (range:
58e86 years). Twenty (67%) patients were refused open
surgery mainly for the extent of the disease combined with
co-morbidity. Thirteen (43%) patients had previous aortic
surgery (open (nZ 11), EVAR (nZ 2)). Ten (33%) patients
had a hostile abdomen due to multiple previous laparoto-
mies. The type of the aneurysm was as follows: TAAA I,
nZ 8; TAAA II, nZ 5; TAAA III, nZ 12; and TAAA IV, nZ 5.
The mean (SD) diameter of the aneurysm was 70 9 mm
(range: 55e100 mm). Further patient demographics are
shown in Table 2.
The devices used were all individually tailored Zenith
stent grafts (Cook Medical Inc., Brisbane, Australia). All
types of fenestrations, scallops and branches were used,
dictated by the individual anatomy. For TAAA type I, scal-
lops were sometimes used distally for the coeliac and
superior mesenteric artery, in order to land the distal edge
of the graft just above the renal arteries. Similarly, when
branches were used for TAAA type I, scallops were some-
times used to incorporate the renal arteries. Fenestrations
were preferentially used if the main body of the stent graft
had contact with the wall of the aorta and the orifice of the
target vessel, or only a short gap to be bridged. Branches
were mainly used in those situations where a longer gap had
to be bridged from the branch towards the orifice of the
target vessel.17Table 2 Patient demographics own series.
Diabetes mellitus 3 (10%)
Hypertension 27 (90%)
Hypercholesterolaemia 25 (83%)
Smoking 18 (60%)
Cardiac disease 20 (67%)
Carotid disease 2 (7%)
Pulmonary disease 24 (80%)
Renal disease 16 (53%)
Previous aorta surgery 13 (43%)
Hostile abdomen 10 (33%)
ASA class 2 3 (10%)
3 22 (73%)
4 5 (17%)In total 97 fenestrations/branches for a possible 120
visceral vessels were targeted: 45 branches directed
downwards, six branches directed upwards, 27 fenestra-
tions and nine scallops. Fourteen aortic side branches were
already occluded at the time of diagnosis: three right renal
arteries, five left renal arteries, one superior mesenteric
artery and five (three complete, two near occlusions)
coeliac arteries. The remaining nine visceral vessels, all
renal arteries in type I TAAA, did not require incorporation
of the stent graft. Coverage of the descending thoracic and
abdominal aorta was an estimated 50% in eight patients,
75% in 15 patients and 100% in the remaining seven
patients. In the majority of cases, balloon-expandable
stents (Advanta, Atrium Medical Corporation, Hudson, NH,
USA, or Jomed Covered Stent Graft, Jomed International
AB, Helsingborg, Sweden) were used to bridge the branches
of the stent graft to the target vessels. Additional support
to prevent kinking was usually achieved with self-expand-
able stents (Zilver Stent, Cook Medical Inc., Bloomington,
IN, USA, or Smart Stent, Cordis, Miami, FL, USA). All but one
operation were performed under general anaesthesia, and
in 19 (63%) cases a spinal catheter was inserted for drainage
of the spinal fluid. Access was gained through the groins and
in 23 (77%) cases also through an upper access site,
including the brachial artery (nZ 3), the axillary artery
(nZ 14), the subclavian artery (supraclavicular approach,
(nZ 2), infraclavicular approach (nZ 3)) and the left
common carotid artery (nZ 1).
Results
Technical success was achieved in 28 (93%) patients. In two
patients target vessels were lost. In the first patient a renal
artery ruptured during inflation of the bridging stent graft,
which was inadvertedly positioned inside a smaller side
branch of the renal artery. This unfortunately happened in
a patient with a single kidney, therefore resulting into
dialysis. In the second patient it proved impossible to
catheterise a heavily stenosed coeliac artery. Due to
catheterisation attempts, the coeliac artery occluded; the
branch on the main stent graft was covered with a cuff in
order to seal the endoleak.
Adjunctive manoeuvres were required in seven (23%)
patients. Rupture of a vessel (aortic arch (nZ 1), external
Figure 1 KaplaneMeier survival curve of TAAA patients
treated with branched endovascular repair.
Figure 2 Influence of previous aortic interventions on
patient survival rate after branched endovascular TAAA repair.
(log rank test: 0.032.)
158 E.L. Verhoeven et al.iliac artery (nZ 1)) occurred in two patients: both were
immediately treated with additional stent grafts. In further
two patients laparotomies were needed for access, one
planned for catheterisation of a left renal artery, one
unplanned to create an aortic conduit in view of an
impossible iliac access. In two cases arteriosclerotic
complications had to be resolved: in the first case by
stenting a stenosed external iliac artery, in the second case
by repairing a damaged common femoral artery. Finally, in
one patient, torsion occurred in the distal stent of the
proximal fenestrated graft due to repositioning inside
a previous surgical graft. This resulted in an insufficient
overlap between the fenestrated tube graft and the bifur-
cated graft, and was treated with an additional cuff.
Two (6.7%) patients died within 30 days. The patient
with the ruptured arch died on the first postoperative day
as a result of multiple organ failure. A second patient died
on postoperative day 8 due to massive gastro-intestinal
bleeding. Autopsy revealed ulcers in the stomach and an
ischaemic distal oesophagus. The patient had an open
repair for TAAA type IV 10 years before this procedure.
Complications were seen in 13 (43%) patients, including
three cardiac complications (STEMI (nZ 2), atrial fibrilla-
tion (nZ 1), two respiratory complications and one urinary
tract infection. One patient required dialysis as mentioned
above, and one patient had a glomerular filtration rate
decrease of more than 30%. Two retroperitoneal haemato-
mas were managed with transfusion and conservative
measurements. Symptoms of paraparesis/paraplegia were
seen in five (16.7%) patients, of which two had previous
open aortic surgery (abdominal (nZ 1), type IV TAAA
(nZ 1). In two patients, continued drainage of spinal fluid
and raise of systolic blood pressure resulted in resolution of
the symptoms; in two more patients spinal catheters were
immediately inserted: one patient was discharged home
without symptoms; the second patient died on post-
operative day 8 as mentioned above. The last patient had
his spinal catheter removed on day 1, but an acute onset of
paraplegia occurred later that day in concert with a systolic
blood pressure drop. A spinal catheter was immediately re-
inserted, which relieved the symptoms. The following day,
he underwent a sigmoid resection for ischaemic colitis.
There were otherwise no re-interventions during the
admission period.
The mean operation time was 286 78 min (range:
135e480 min); median blood loss was 570 ml (range:
100e5500 ml). The mean contrast used was 277 92 ml
(range: 80e480 ml) and the mean fluoroscopy time was
74 29 min (range: 15e140 min). Half of the patients
required admission to the intensive care unit after the
procedure. The median stay in intensive care unit was 1 day
(range: 0e28 days). The median hospital stay was 8 days
(range: 3e50 days).
The mean follow-up was 12 months (range: 1e57
months), during which five patients died: two as a result of
myocardial infarction, one after pneumonia and in two
cases the patients died in poor general condition without
a specified cause of death. Six months and 1-year survival
were 89.3% and 76.0%, respectively, as shown in Fig. 1. On
univariate analysis, previous aortic surgery (EVAR) and
occlusion of one or both renal arteries were predictors for
mortality (Figs. 2 and 3). On multivariate analysis, however,these factors turned out not to be independently predictive
for mortality.
During follow-up, one patient suffered occlusion of both
renal arteries at 3 months, which required dialysis. This
late event occurred in the second patient of our series due
to kinking of the two renal artery branches (Fig. 4). In this
patient, the balloon-expandable bridging stent grafts were
not relined with additional self-expandable stents. One
additional target vessel occluded at 30 months but without
symptoms (coeliac artery covered by a scallop in a type I
TAAA). One more patient experienced renal function
deterioration of more than 30%, but his single kidney renal
artery showed to be fully open. Overall patency estimate of
target vessels is shown in Fig. 5, and has remained well over
90% over time. KaplaneMeier analysis of patency stratified
after type of bridging stent graft showed excellent results
for downward-facing branches relined with self-expandable
stents (Figs. 6 and 7).
Figure 3 Influence of occlusion of one or both targeted renal
arteries on patient survival rate after branched endovascular
TAAA repair. (log rank test: 0.048.)
Figure 5 Overall target vessel patency curve.
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including endovascular treatment of a stenosis in the
coeliac trunk at 3 months, and a femoro-femoral crossover
bypass after occlusion of a prosthetic limb at 14 months in
the same patient.
Discussion and future perspectives
At this moment, patients with TAAA are still mostly offered
open repair. However, many patients are rightfully notFigure 4 Postoperative angiography of 76-year-old female
with TAAA type III treated with a four branched stent graft,
which resulted in kinking (arrows) of both renal artery
branches.considered for treatment because of age and/or co-
morbidity. Alternative treatment techniques have emerged
over the last years. Some favour a ‘hybrid approach’
combining surgical de-branching of the visceral side
branches of the aorta with an endovascular relining of the
aorta.28e30 This method is less invasive than a standard
open repair, but still requires a laparotomy and temporary
interruption of visceral artery blood flow. A fully endovas-
cular repair has the potential to overcome these problems
and to be less invasive.
Our results are promising in view of the high-risk group
that was treated, and are in concordance with the other
publications. In addition, a learning curve has to be taken
into account, with a technique in full evolution. With
dedicated bridging stent grafts, the procedure would gain
in simplicity and probably efficacy. At this moment, we
have to resort to stiffer balloon-expandable bridging stent
grafts that have the advantage of accurate positioning, and
relining with self-expandable stents to prevent kinking.
However, this technique seems to work as demonstrated by
the patency rates (Fig. 7).Figure 6 Target vessel patency curves stratified after type of
bridging stent graft (log rank test 0.004).
Figure 7 Target vessel patency curves stratified after type of
relinement of the targeted vessels with stents (log rank test
0.196).
160 E.L. Verhoeven et al.Planning is probably evenmore important thanexecution.
Each graft should be designed according to the unique
anatomy of the patients’ aneurysm. Fenestrations work well
when they can be approached from the contralateral
femoral artery, and when the gap between the graft and the
target vessel is small. After deployment, the bridging stent
graft is flared on the inside of the main graft with a larger-
diameter balloon, and should remain in a stable position.
When the gap to bridge becomes bigger, this connection
becomes instable. A directional branch has the advantage of
providing a longer fixation and sealing zone.Wedo customise
our grafts to the patients’ anatomy, but have found a mix of
branches and fenestrations very appealing. This can include
fenestrations for the renal arteries and downward-facing
branches for the coeliac and superior mesenteric arteries.
This also allows for a more natural angle and position for the
bridging stent grafts in view of the take-off angle of the
respective vessels. Upward-facing branches are sometimes
useful for the renal arteries but seem to be inferior to
downward-facing branches (Fig. 6)
A selection bias is undoubtedly present in all the pub-
lished endovascular series, including the present series,
and should be acknowledged, but more challenging cases
were successfully managed with increasing experience.
This is the most probable explanation for the rising numbers
in our centre. There is indeed a clear increase of cases
(2004 (nZ 4), 2006 (nZ 3), 2007 (nZ 5), 2008 (nZ 10),
2009/4 (nZ 8)), which cannot be explained by referral
patterns only. This selection bias is true for any of the
treatment options for TAAA. Where open treatment pre-
selects the patients more on the absence of severe co-
morbidity and age below 75, rather than on anatomical
difficulty, fully endovascular repair and to a lesser extent
the hybrid procedure have to comply to inclusion criteria
such as access and suitable landing zones. In our series,
nine patients were over 75, and 20 patients were refused
open surgery. As mentioned above, we gradually take on
more challenging cases, for example, with severe
angulations or stenosed target vessels.The future will probably see an increase of endovascular
procedures for TAAA, even without level I evidence, in view
of the major impact of open repair, which will remain an
option for some younger and healthier patients, and
patients who are not suitable for EVAR. The hybrid
approach will be reserved for some specific anatomies only,
in patients who cannot have an EVAR, or patients who need
urgent repair. Finally, it is to be expected that a fewer
patients will be refused treatment at all in view of the
increasing technical options.
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